Skip to main content
. 2013 Sep 12;25(1):55–64. doi: 10.1681/ASN.2013050453

Table 2.

Reported disease-related variants

Gene Nucleotide AA Change PSa Related Disease MAFb (EVS_EA) dbSNP 137
C9 c.460 C>T p.R154X C9 deficiency50 0.0002 rs144138616
CD46 c.692 C>G p.P231R 6 aHUS51 ND ND
CD46 c.648 G>C p.W216C 6 aHUS51 ND ND
CD46 c.565 T>G p.Y189D 5 aHUS52 ND ND
CFB c.967 A>C p.K323Q 2 aHUS51 ND ND
CFH c.1825 G>A p.V609I 1 aHUS51 0.0006 rs148165372
CFH c.1873 G>T p.E625X aHUS51 0.0002 rs150694809
CFH c.2745 C>A p.C915X aHUS51 ND ND
CFH c.3514 G>T p.E1172X aHUS53 ND rs121913060
CFH c.3583 G>T p.E1195X aHUS51 ND ND
CFH c.3592 G>A p.E1198K 4 aHUS54 ND ND
CFH c.3643 C>G p.R1215G 4 aHUS7 ND rs121913051
CFH c.3644 G>Ac p.R1215Q 2 aHUS55 ND ND
CFI c.355 G>A p.G119R 3 aHUS51 0.0013 rs141853578
CFI c.859 G>A p.G287R 5 aHUS51 0.0001 rs182078921
F12 c.1681–1 G>A NA Factor XII deficiency30 0.0006 ND
PLG c.112 A>G p.K38E 5 Plasminogen deficiency26 0.0062 rs73015965
PLG c.2134 G>A p.G712R 3 Plasminogen deficiency27 0.0007 ND
PLG c.758 G>A p.R253H 5 Plasminogen deficiency28 0.0006 rs143034754
THBD c.1502 C>T p.P501L 3 aHUS23 0.0029 rs1800579
VWF c.2561 G>A p.R854Q 4 Von Willebrand disease56 0.0056 rs41276738

All variants are heterozygous. AA, African-American; EA, European-American; C9, complement component 9; F12, coagulation factor XII; VWF, Von Willebrand factor; NA, not available; ND, no data.

a

Pathogenicity score (PS) was calculated using PhyloP, SIFT, PolyPhen2, LRT, MutationTaster, and GERP++. The average PS of reported disease-related variants was 3.81.

b

Minor allele frequency (MAF) values in the European-American population are from the Exome Variant Server (EVS). Novel variants are those variants not reported in the EVS, 1000 Genomes, or dbSNP databases.

c

Mutation is carried by two patients.

HHS Vulnerability Disclosure